Stevioside induced ROS-mediated apoptosis through mitochondrial pathway in human breast cancer cell line MCF-7

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 1087-1094

  Paul, S ^a   Sengupta, S ^b   Bandyopadhyay, T K ^a   Bhattacharyya, A ^b  

^a UNIVERSITY OF KALYANI   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 9; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; STEVIOSIDE; TRANSCRIPTION FACTOR NRF2;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 9; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSIDES; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIALS; MITOCHONDRIA; NF-E2-RELATED FACTOR 1; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84867790336     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.712735     Document Type: Article

References (29)

1. Hulka, B S, and, Moorman, P G. 2001. Breast cancer: hormones and other risk factors. Maturitas, 38: 103-113.
2. Benjamin, C W, Hiebsch, R R, and, Jones, D A. 1998. Caspase activation in MCF7 cells responding to etoposide treatment. Molecular Pharmacology, 53: 446-450.
3. Newman, D J, Cragg, G M, and, Snader, K M. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat. Prod, 66: 1022-1037.
4. Geuns, J M. 2003. Stevioside. Phytochemistry, 64: 913-921.
5. Chen, T H, Chen, S C, Chan, P, Chu, Y L, Yang, H Y. 2005. Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. Planta Med, 71 (2): 108-113.
6. Hsieh, M H, Chan, P, Sue, Y M, Liu, J C, Liang, T H. 2003. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebocontrolled study. Clin Ther, 25: 2797-2808.
7. Yasukawa, K, Kitanaka, S, and, Seo, S. 2002. Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Biol Pharm Bull, 25 (11): 1488-1490.
8. Takasaki, M, Konoshim, T, Kozuka, M, Tokuda, H, Takayasu, J. 2009. Cancer preventive agents: Part 8. Chemopreventive effects of stevioside and related compounds. Bioorganic & Medicinal Chemistry, 17: 600-605.
9. Melis, M S. 1992. Stevioside effect on renal function of normal and hypertensive rats. J Ethnopharmacol, 36: 213-217.
10. Boonkaewwan, C, Ao, M, Toskulkao, C, and, Rao, M C. 2008. Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells. J Agric. Food Chem, 56: 3777-3784.
11. Thompson, C B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science, 267: 1456-1462.
12. West, J D, and, Marnett, L J. 2006. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol, 19: 173-194.
13. Budihardjo, I, Oliver, H, Lutter, M, Luo, X, and, Wang, X. 1999. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol, 15: 269-290.
14. Orrenius, S. 1993. Mechanisms of oxidative cell damage. In Free radicals: from basic science to medicine, Edited by: Pol, G, Albano, E and Dianzani, M U. 47-64. Basel, Switzerland: Birkhauser Verlag.
15. Vaux, D L, and, Korsmeyer, S J. 1999. Cell death in development. Cell, 96: 245-254.
16. Shih, C M, Ko, W C, Wu, J S, Wei, Y H, Wang, L F. 2004. Mediating caspase-independent apoptosis by cadmium through mitochondria-ROS pathway in MRC-5 fibroblasts. J. Cell. Biochem, 91: 383-397.
17. Hsu, Y H, Liu, J C, Kao, P F, Lee, C N, Chen, Y J. 2002. Antihypertensive effect of stevioside in different strains of hypertensive rats. Chin Med J, 65: 1-6.
18. Roos, W P, and, Kaina, B. 2006. DNA damage-induced cell death by apoptosis. Trends Mol Med, 12: 440-450.
19. Bradham, C A, Qian, T, Streetz, K, Trautwein, C, Brenner, D A. 1998. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol, 18: 6353-6364.
20. Grimm, S, and, Brdiczka, D. 2007. The permeability transition pore in cell death. Apoptosis, 12: 841-855.
21. Tadhani, M B, Patel, V H, and, Subhash, R. 2007. In vitro antioxidant activities of Stevia rebaudiana leaves and callus. Journal of Food Composition and Analysis, 20: 323-329.
22. Halliwell, B, and, Gutteridge, JMC II. 1989. Free Radicals in Biology and Medicine, Oxford, UK: Clarendon.
23. Korsmeyer, S J. 1995. Regulators of cell death. Trends Genet, 11: 101-105.
24. Alnemri, E S, Livingston, D J, Nicholson, D W, Salvesen, G, Thornberry, N A. 1996. Human ICE/CED-3 protease nomenclature. Cell, 8: 71
25. Bargou, R C, Daniel, P T, Mapara, M Y, Bommert, K, Wagener, C. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low baxalpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60: 854-859.
26. Hu, H, Ahn, N S, Yang, X, Lee, Y S, and, Kang, K S. 2002. Ganoderma lucidumextract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int. J. Cancer, 102: 250-253.
27. Yuan, J Y, Shaham, S, Ledoux, S, Ellis, H M, and, Horvitz, H R. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 75: 641-652.
28. DAutreaux, B, and, Toledano, M B. 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol, 8: 813-824.
29. Zhang, Y, and, Gordon, G B. 2004. A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther, 3: 885-893.